Clinical Trial: PA.RI.GE. Study. The Prognostic Role of Inflammatory Circulating Biomarkers in HNSCC: a Prospective Multicentric Trial

U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT06809673) titled 'PA.RI.GE. Study. The Prognostic Role of Inflammatory Circulating Biomarkers in HNSCC: a Prospective Multicentric Trial' on Jan. 30.

Brief Summary: This is a clinical, observational, non-pharmacological, multicenter, prospective case-control no-profit study to assess the prognostic role of several circulating inflammatory biomarkers

Study Start Date: Aug. 01, 2024

Study Type: OBSERVATIONAL

Condition: Head and Neck Cancer

Intervention: OTHER: blood sampling

blood sampling at baseline, 1,3,6 months after surgery and eventually when recurrence is detected.

If adjuvant treatment is planned, blood sampling at baseline, 1 month afte...